Epilepsy Awareness – Purple Day: Reframing Neurological Leadership
- Posted by Greg Wahlstrom, MBA, HCM
- Posted in Health Observance Calendar
Mobilizing Executive Strategy to Support Epilepsy Awareness and Patient Advocacy
Published: March 26, 2025
Hospital executives observing Purple Day for Epilepsy Awareness on March 26, 2025, face a strategic opportunity to integrate neurological equity into their long-term clinical agendas. With over 3.4 million Americans living with epilepsy, many remain underserved due to diagnostic delays, stigma, and gaps in care coordination. At the Cleveland Clinic, epilepsy programs have merged AI-powered seizure monitoring with digital health coaching, providing a strong example for executives aiming to modernize care models. But awareness must move beyond clinical silos—CEOs must position epilepsy as a critical marker of inclusive neuroscience leadership. As the National Association of Epilepsy Centers continues to push for system-based solutions, hospital boards must reassess resource distribution, diagnostic equity, and community education. Purple Day is not just a symbolic gesture—it is a reminder that neurological dignity requires boardroom advocacy.
From a systems perspective, epilepsy demands high-level coordination across emergency response, neurology, pharmacy, and digital health departments. Institutions like Mayo Clinic have implemented multidisciplinary seizure care pathways that dramatically reduce wait times for diagnosis and intervention. Executives overseeing integrated networks should evaluate the scalability of similar initiatives. Additionally, epilepsy intersects with social determinants of health, particularly in populations with limited access to neurologists. For example, the national shortage of neurologists in rural and underserved areas magnifies disparities. By investing in mobile neurology consults, tele-EEG platforms, and workforce incentives, leaders can actively reduce these systemic blind spots. Operational excellence in this domain means optimizing both infrastructure and inclusion—where leadership accountability must be clear and metrics-driven.
Communication strategy also plays a defining role in elevating epilepsy awareness. Executives must ensure that marketing, public relations, and community partnerships reflect contemporary epilepsy realities. The Epilepsy Foundation has pioneered data-driven campaigns that blend advocacy with accessible science. These models should inform how hospitals engage their local communities during awareness days. Moreover, executive leadership teams should involve individuals with epilepsy in shaping institutional messaging, ensuring dignity and clarity. Storytelling can be a powerful tool for de-stigmatization, especially when paired with actionable education on seizure response and care pathways. Leaders should also train front-line and managerial staff through interactive simulations and e-learning tools provided by validated national organizations. In the age of consumer trust volatility, authentic, representative communication is both a duty and a competitive differentiator.
Workforce development remains central to advancing epilepsy care across all touchpoints. Chief Nursing Officers and HR executives should partner on credentialing programs that equip clinical teams with seizure response certification and cultural fluency. At Massachusetts General Hospital, continuing education modules on neurological diversity have reduced emergency escalation events and improved caregiver confidence. As organizations pursue strategic staffing solutions, epilepsy training should be embedded into cross-functional workforce plans. Further, boards should evaluate whether C-suite development pipelines include executives with neuroscience, disability advocacy, or digital therapeutics expertise. Governance innovation begins with cognitive inclusion—empowering executives to lead with data, empathy, and cross-sector collaboration. Purple Day should be a springboard for executive reflection, HR reform, and policy reevaluation.
Globally, epilepsy is a major public health concern affecting over 50 million people, making international collaboration essential. The World Health Organization’s Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders offers a framework for systemic reform and accountability. U.S. health systems can localize these global priorities by forming coalitions with academic centers, patient organizations, and tech innovators. Executives should monitor breakthrough research in seizure forecasting, non-invasive treatment options, and wearable technology. Equally important is their advocacy role in policy reform, insurance parity, and legislative protections for people with epilepsy. March 26 is not just Purple Day—it is a litmus test for whether executive teams are ready to lead with vision, equity, and neurological integrity. At The Healthcare Executive, we believe that hospitals capable of treating the brain must also lead with it.
Discover More
For more executive insights on advancing neurological care and community-integrated health strategy, explore our related post on executive solutions to the healthcare workforce crisis.
